Samples- Travel

Travel

cialis , buy levitra , xenical

Posted by GuyJ on Fri 25 Apr 2008 10:20:06 PM PDT

asdasd

Although the men on testosterone did eventually have more lean body mass and less fat mass compared to those on the placebo, they did not have improved functional mobility, muscle strength, cognition function or bone mineral density, the researchers...

Although the men on testosterone did eventually have more lean body mass and less fat mass compared to those on the placebo, they did not have improved functional mobility, muscle strength, cognition function or bone mineral density, the researchers found. Those on testosterone did have improved insulin sensitivity, but HDL (high-density lipoprotein) cholesterol went down - HDL is the good cholesterol.
By the end of the six month period 47.8% of those on health
health
health
health
health
health
health
health
health
health
health
health
health
health
health
health
health
health
health
health
health
health
health
health
health
health testosterone versus 35.5% of those on the placebo had metabolic syndrome - not considered a statistically significant difference.
The researchers report that quality-of-life measures were not different among the two groups, except for hormone-related quality of life. Adverse events between the two groups were not statistically different.
Testosterone supplementation was linked to an increase in blood creatinine concentrations, a measure of kidney function, and hemoglobin and hematocrit, two red blood cell measures. They also detected no negative effects on prostate safety from testosterone supplementation.
blogeregg
acuaworld
applecool
asusnet
The researchers wrote "This study is, as far as we know, the largest study of testosterone supplementation with the most end points and a randomized, double-blind design. Adherence was high and the dropout rate was low. The findings in this study do not support a net benefit on several indicators of health and functional and cognitive performance with 6 months of modest testosterone supplementation in healthy men with circulating testosterone levels in the lower range."
"Effect of Testosterone Supplementation on Functional Mobility, Cognition, and Other Parameters in Older Men - A Randomized Controlled Trial"
Marielle H. Emmelot-Vonk, MD; Harald J. J. Verhaar, MD, PhD; Hamid R. Nakhai Pour, MD, PhD; Andre Aleman, PhD; Tycho M. T. W. Lock, MD; J. L. H. Ruud Bosch, MD, PhD; Diederick E. Grobbee, MD, PhD; Yvonne T. van der Schouw, PhD
Approximately one in every 500 to 650 baby boys is born with an extra X chromosome, a variation in their genetic code that until a few years ago was thought to result in infertility in all cases. However, this is no longer the case. A recent conference hosted by NewYork-Presbyterian Hospital/Weill Cornell Medical Center and advocacy organization KS&A focused on raising awareness of the condition and the recent availability of treatments for both children and adults.
lovemeal
makingmoneywithebay
med2010
medicoportal
megacoolnews
megadoctor
meganicotine
msnru
narcot
nncnn
omegafishoil
paperosa
pdds
pendolf
pleomaxxx
popmed
pornoearth
postol
prezicdent
pytinka
qaction
rosgos
sexfatality
sexprovision.com
shambler
shemoskva
shlenics
softorym
soloveyy
spacenewsw
sportboxing
ssmokingg
stomed
streepshoy
streetsparkiing
teleportools
timereeder
topyeti
urban-stream
vegaslights
veromaxx.com
vislandia
vodo4ka
vsevcredit
watchrool
wexmoney
As recently as 10 years ago, all men born with an extra X chromosome -- a condition whose classic symptoms are known as Klinefelter syndrome -- were thought to be infertile. Now, new research at NewYork-Presbyterian/Weill Cornell, led by Dr. Peter Schlegel, has pioneered a surgical approach -- a combination of TESE (testicular sperm extraction) and IVF (in vitro fertilization) -- that enables these men to father healthy children approximately 40 percent of the time it is employed.
But this is just the beginning. "Our Department has five scientists who are leading research into Klinefelter's and other chromosomal variations. We are very pleased to join forces with KS&A to raise awareness for these conditions," says Dr. Schlegel, chairman of the Department of Urology and professor of urology and reproductive medicine at Weill Cornell Medical College, and urologist-in-chief at NewYork-Presbyterian/Weill Cornell.
KS&A presented Dr. Schlegel with a "Lifetime Achievement Award" at its recent meeting to honor his infertility treatment advances -- which are rewriting the textbook on Klinefelter syndrome.
"Our current research in the laboratory focuses on understanding the mechanism by which the presence of an additional X chromosome affects sperm production andgreatstress
homeshoppingdirectory
info2011
infofreestyle
infonedvigimost
infonewsinfo
integrationol
kadishop
kybdbdky testosterone synthesis in males health
health
health
health
health
health
health
health
health
health
health
health
health
health
health
health
health
health
health
health
health
health with Klinefelter syndrome. These critical and unique studies will allow us to provide improved treatment and management recommendations based on solid understanding of underlying pathophysiology," says Dr. Darius A. Paduch, assistant professor of urology and reproductive medicine at Weill Cornell Medical College and assistant attending urologist at NewYork-Presbyterian/Weill Cornell.
Dr. Paduch, who leads NewYork-Presbyterian/Weill Cornell's translational research into the molecular biology and genetics of 47XXY and Klinefelter syndrome, has assembled a diverse group of scientists from Cornell-Ithaca and Rockefeller University to create a center of excellence in research on Klinefelter syndrome. The Center will be one of the first nationally comprehensive resources for patients of all ages dedicated to variations in the X and Y chromosomes.
comedy-club
coolmygames
cosmossworld
dbdblog
dbloggera
3dnews3d
4ernobil
europa-gopa
fishkay
flip-top
The unique meeting brought together national expertise in molecular biology and genetics of reproduction and molecular endocrinology. Each of the scientists who participated in the conference -- Weill Cornell's Dr. Matthew Hardy, an adjunct professor of urology, and Cornell-Ithaca's Dr. Paula Cohen, associate professor of genetics, as well as Dr. Alex Travis, assistant professor of reproductive biology -- offer unique expertise in basic science, which, combined with access to patients seen in the Department of Urology, will allow for multidisciplinary collaborations focused on basic scientific research to improve patient care.
"We are very pleased to join with NewYork-Presbyterian/Weill Cornell, whose important research is a cornerstone for a growing body of knowledge that will help transform the lives of individuals who have X and Y chromosome variations," says Robert Shelton, chairman of the Board of Directors of KS&A. "There is a high likelihood that research into these chromosomal variations will make substantial contributions to knowledge about breast cancer, learning disabilities and other seemingly unrelated phenomena as more is discovered concerning the relevance of genes located on the X and Y chromosomes."
bil9gates
biofilterservice
bl9dstvo
bloggegg.com
camedy
capitaltop
Most individuals have a total of 46 chromosomes. Commonly, men have one X and one Y chromosome; and women have two X chromosomes. But this is not true for everyone. The most common variation is 47XXY in boys and Trisomy X in girls. Without proper interventions, boys born with an extra X chromosome are at a significantly heightened risk of developing the signs and symptoms of Klinefelter syndrome as adults. Unlike other genetic syndromes such as Down's or Fragile X, comparatively little is known about X and Y chromosome variations. NewYork-Presbyterian/Weill Cornell and KS&A are working diligently to change that.
bestonlinedatingservice
big-bigpills
cnewsc
fotokosmos
galaxycal
gandyrasovka
getstress
goldmoneykey
gradusnik
literbollfurniture-with-style
wmyblog
w-news-w
world2010
Isolagen initiates a Phase III clinical program to investigate Isolagen Therapy for the treatment of moderate to severe acne scars. Isolagen also has a pivotal Phase III clinical program underway to evaluate the Isolagen Therapy in treating nasolabial folds, or wrinkles.

"Millions of people in the U.S. suffer from acne which often scars, a condition that can be very distressing and difficult to treat as there are few options currently available," said Nicholas L. Teti, Jr., Chairman and Chief Executive Officer of Isolagen. "We are pleased to be initiating this important clinical development program which we believe will address this largely unmet medical need."
health
health
health
health
health
health
health
health
health
health
health
health
health
health
health

Posted by WORLDINSOFT on Mon 14 Apr 2008 09:10:05 AM PDT

foetus

Investigating Isolagen Therapy For Treatment Of Acne Scars

Isolagen initiates a Phase III clinical program to investigate Isolagen Therapy for the treatment of moderate to severe acne scars. Isolagen also has a pivotal Phase III clinical...

Investigating Isolagen Therapy For Treatment Of Acne Scars

Isolagen initiates a Phase III clinical program to investigate Isolagen Therapy for the treatment of moderate to severe acne scars. Isolagen also has a pivotal Phase III clinical program underway to evaluate the Isolagen Therapy in treating nasolabial folds, or wrinkles.
Buy Cialis Online
"Millions of people in the U.S. suffer from acne which often scars, a condition that can be very distressing and difficult to treat as there are few options currently available," said Nicholas L. Teti, Jr., Chairman and Chief Executive Officer of Isolagen. "We are pleased to be initiating this important clinical development program which we believe will address this largely unmet medical need."
Cheap Viagra Online
Two randomized, double-blind, placebo-controlled trials will evaluate the safety and efficacy of Isolagen Therapy in patients with moderate to severe acne scarring on both sides of the face. All patients in the study will receive active treatment on one side of the face and placebo on the other, serving as their own control subjects. The patients will receive three injections, two weeks apart, and be followed for a four month period after final injection.
Pharmacy Online - Discount in Drugs
About Acne Scarring
Buy Celebrex
Acne is one of the most common skin disorders in the United States. viagra online Buy Viagra order viagra Over time, as facial tone declines and facial fat stores are depleted, acne scars typically become more noticeable. Current treatments for acne scarring include dermabrasion, laser resurfacing, surgical excision, and certain.
Aesthera's Breakthrough Painless Isolaz Therapy For Acne

Order Fosamax

Aesthera Corporation's Isolaz painless acne therapy has been featured in the September issue of Vogue, the most widely read issue of the year. Featured as a unique treatment that gets rid of acne fast, the Isolaz therapy is mentioned as the first laser approved by the FDA to treat severe acne.

"I haven't been this excited by a treatment in years," stated Jancee Dunn, Contributing Beauty Writer for Vogue and author of the piece. "The Isolaz completely cleared up the acne that had plagued me for ten years and vanquished all of my fine lines and sun damage. After the treatments, I could not stop touching my velvety skin. I am making standing appointments every month."
Popular pills
Ms. Dunn's dermatologist, the renowned Dr. Frederic Brandt is also a fan of the treatment, "The Isolaz painless laser facial is one of the most innovative and effective in-office treatments for acne and skin rejuvenation that I have seen in years."

Aesthera's Isolaz is the only system FDA cleared to treat comedonal and pustular acne. The Isolaz therapy is also cleared to treat mild to moderate, inflammatory acne and acne vulgaris

In addition to Vogue, the Isolaz therapy has also been featured in the August issue of Harper's Bazaar and the September issue of Elle magazine as a new breakthrough treatment to effectively minimize and clear pores on a long- term basis.
Pills Online
A recent clinical study also showed that, in addition to acne reduction, 64 percent of acne patients who had not responded to oral medications, topicals and traditional lasers in the past had shown greater than a 75 percent clearance of acne lesions after treatment with the Isolaz system. After four treatments, an 88 percent reduction in papular, pustular, comedonal and nodular acne was observed.

Spot on treatment for acne
Order Tramadol
Buy Ultram
Acne Treatment Drug
A previously unknown side effect of an unnamed drug currently on the marketplace could be useful for treating acne, reports Chemistry & Industry, the magazine of the SCI. A UK company is about to start a Phase 1 trial with the drug involving 18 healthy human volunteers and the results are expected to be announced later this year. In an earlier Phase 1 study in nine healthy human volunteers, the treatment was seen to reduce the excretion of sebum by the skin, which is associated with acne development, by up to 70%.
Buy Kamagra Online
'The Phase I results are startlingly good,' said Nigel Blackburn, director of clinical development at the company, Summit, which is organising the trial. 'Reducing sebum production has been the "holy grail" of acne treatment for 30 years, and there has been little success aside from Roaccutane which has significant side effects.'
Cheap Viagra
The current 'gold standard' for acne treatment, Roaccutane can cause a wide range of side effects, including teratogenicity a€“ which leads to abonormalities in the unborn foetus of pregnant women, and has also recently been linked to depression and (inconclusively) to teenage suicides. The market for acne treatments is worth several billion dollars, and any new treatment developed without side effects could potentially reap blockbuster sales.

Although Summit has not disclosed the name of the drug now under evaluation, the company says it represents an entirely new class of compounds for treating acne. 'At the doses we are looking at any side effects should be mild compared with those resulting from Roaccutane treatment,' Blackburn commented.
Cheap Viagra Online
The company hopes to begin critical Phase 2 trials to assess the efficacy of the drug in acne sufferers next year. Depending on the results, the drug could either be formulated as a stand-alone topical treatment or more likely in combination with other existing treatments. The company has already been in talks with several interested companies, who are waiting to see whether the initial results can be repeated in a larger study group.

Posted by COMPIKNEWS on Mon 24 Mar 2008 01:28:45 AM PDT